Program By Day

7:00 AM-6:15 PM Exhibits Open
7:00 AM-7:45 AM Complimentary Continental Breakfast
7:45 AM-9:30 AM Welcome and General Session 1: Diagnosis and Multimodality Treatment of Localized Disease

Christopher J. Kane, MD—Chair
University of California, San Diego

Thomas J. Pugh, MD—Chair
The University of Texas MD Anderson Cancer Center

Daniel W. Lin, MD
University of Washington
Welcome

Case-Based Debate: Magnetic Resonance and Magnetic Resonance-Directed Biopsy: Where Is the Field Moving?

Christopher J. Kane, MD
University of California, San Diego
Moderator

TBD
Radiologist

Caroline Moore
University College London
Urologist

Mary-Ellen Taplin, MD
Dana-Farber Cancer Institute
Newly-Diagnosed High-Risk Disease Treatment: Summarizing Neoadjuvant Trials

Alberto Briganti, MD, PhD
Vita-Salute San Raffaele University, Urological Research Institute, IRCCS Ospedale San Raffaele
Adjuvant Radiotherapy and Chemotherapy in Node-Positive Disease

Case-Based Debate: Treating High-Risk Patients After Prostatectomy: Adjuvant Therapy Versus Early-Salvage Therapy

TBD
Moderator

TBD
Adjuvant Advocate

William U. Shipley, MD, FACR
Massachusetts General Hospital, Harvard Medical School
Early-Salvage Advocate

Panel Question and Answer
9:30 AM-10:00 AM Break
10:00 AM-11:30 AM General Session 2: Emerging Diagnostics and Therapies in Advanced Prostate Cancer

William L. Dahut, MD—Chair
National Cancer Institute

Himisha Beltran, MD—Chair
Weill Cornell Medical College

TBD
Emerging Immunotherapy Strategies for Castrate Resistant Prostate Cancer

Felix Feng, MD
University of California, San Francisco
Management of Oligometastatic Prostate Cancer From Imaging to Therapy

Kim N. Chi, MD, FRCPC
British Columbia Cancer Agency
Incorporating Genomics Into the Management of Systemic Therapy: Advances and Practicality

Joe M. O'Sullivan, MD, FRCR
Queen's University Belfast
Molecular Therapies in Bone Metastases

Panel Question and Answer
11:30 AM-1:00 PM Poster Session A: Prostate Cancer
With Complimentary Boxed Lunch
11:30 AM-1:00 PM Trials in Progress Poster Session A: Prostate Cancer
With Complimentary Boxed Lunch
12:00 PM-1:00 PM Trainee and Early-Career Networking Luncheon
1:00 PM-2:30 PM Oral Abstract Session A: Prostate Cancer
2:30 PM-3:15 PM Prostate Cancer: Keynote Lecture

TBD
Germline and Somatic Mutational Landscape in Prostate Cancer: State of Knowledge and Implications for Practice
3:15 PM-3:45 PM Break
3:45 PM-5:15 PM General Session 3: Moderated Debates on Controversial Topics in Prostate Cancer

Justin E. Bekelman, MD—Chair
Perelman School of Medicine at the University of Pennsylvania

Francesco Montorsi, MD—Chair
Universita Vita Salute San Raffaele

Case-Based Debate: Is There Evidence for Local Treatment in Patients with Newly Diagnosed Metastatic Disease?

Elisabeth I. Heath, M.D.
Barbara Ann Karmanos Cancer Institute, Wayne State University
Moderator

Mack Roach III, MD, FASCO
University of California, San Francisco
Advocate

Adam Dicker, MD, PhD
Sidney Kimmel Cancer Center
Skeptic

Case-Based Debate: Abiraterone Versus Docetaxel

Nicholas J. Van As, FRCR
The Royal Marsden NHS Foundation Trust
Moderator

Karim Fizazi, MD, PhD
Gustave Roussy, University of Paris Sud
Abiraterone Advocate

Christopher Sweeney, MBBS
Dana-Farber Cancer Institute and Brigham and Women's Hospital
Docetaxel Advocate

Panel Question and Answer
5:15 PM-6:00 PM Rapid-Fire Abstract Session: Prostate Cancer
5:15 PM-6:15 PM Poster Session A: Prostate Cancer, Continued
With Complimentary Wine and Cheese
5:15 PM-6:15 PM Trials in Progress Poster Session A: Prostate Cancer, Continued
With Complimentary Wine and Cheese